Vera Therapeutics, Inc. - stock earnings
VERA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -20.1 million USD | ? USD |
| 2023Q2 | -20.2 million USD | ? USD |
| 2023Q1 | -29.8 million USD | ? USD |
| 2022Q4 | -32.4 million USD | ? USD |
| 2022Q3 | -24.1 million USD | ? USD |
| 2022Q2 | -14.6 million USD | ? USD |
| 2022Q1 | -17.1 million USD | ? USD |
| 2021Q4 | -16.8 million USD | ? USD |
| 2021Q3 | -7.6 million USD | ? USD |
| 2021Q2 | -3.4 million USD | ? USD |
| 2021Q1 | -4.7 million USD | ? USD |
| 2020Q4 | -42.9 million USD | ? USD |
| 2020Q3 | -4.5 million USD | ? USD |
| 2020Q2 | -3.6 million USD | ? USD |
| 2020Q1 | -2.5 million USD | ? USD |
VERA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -102.8 million USD | ? USD |
| 2022 | -89.1 million USD | ? USD |
| 2021 | -32.6 million USD | ? USD |
| 2020 | -53.4 million USD | ? USD |
| 2019 | -11.9 million USD | ? USD |
VERA
Price: $43.44
52 week price:
Earnings Per Share: -2.25 USD
P/E Ratio: -15.11
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 367897
Market Capitalization: 2.6 billion